Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (APR_DRG 18) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 1, 2026 , from http://ppman.hank.ai/transparency/procedure/18/by-state?code_type=APR_DRG
“CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (APR_DRG 18) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/18/by-state?code_type=APR_DRG. Accessed
July 1, 2026 .
“CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES (APR_DRG 18) by State,” HANK Price Transparency ,
accessed July 1, 2026 ,
http://ppman.hank.ai/transparency/procedure/18/by-state?code_type=APR_DRG.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
APR-DRG · across United States
18 — Chimeric Antigen Receptor (car) T-cell And Other Immunotherapies
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$78,976
National median
$77,427 – $468,061
IQR (p25 – p75)
2
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 18 (APR_DRG), with interquartile range
State Median p25 p75
SD $487,371 $444,680 $499,879
PA $77,427 $58,087 $77,814